To assess the accuracy of positron emission tomography to predict recovery of global cardiac function after revascularization in patients with coronary artery disease.
Aims
To assess the accuracy of positron emission tomography to predict recovery of global cardiac function after revascularization in patients with coronary artery disease.
Methods and Results
One hundred and seventy-eight patients (157 male, 58 10 years) with coronary artery disease and left ventricular dysfunction (mean ejection fraction 39 14%) were enrolled in six European centres. They underwent a common protocol for the assessment of viability using 18 F-fluoro-2-deoxyglucose (FDG) positron emission tomography during a standardized euglycaemic hyperinsulinaemic glucose clamp before revascularization by either surgery (n=140) or angioplasty (n=38). Seven patients were excluded because of incomplete revascularization of a dysfunctional region. Based on the recovery of global ejection fraction 2-6 months after revascularization, patients were classified into two groups: 82 patients who had a >5% improvement in ejection fraction postoperatively, and 89 patients without postoperative ejection fraction improvement. Optimal cut-off points for postoperative improvement of global cardiac function were computed, using receiver operating curve analysis. The highest sensitivity (79%) and specificity (55%) for predicting postoperative ejection fraction improvement by positron emission tomography was found when three or more dysfunctional segments had a relative FDG uptake >45% of normal remote myocardium (overall accuracy 67%).
Introduction
Revascularization of dysfunctional, albeit viable myocardium has been shown to improve cardiac function [1] [2] [3] [4] , symptoms of heart failure [5] and survival [6] [7] [8] [9] [10] in patients with coronary artery disease and a low ejection fraction. Because the risk of coronary revascularization is comparatively higher in patients with impaired left ventricular function [11] [12] [13] [14] , the presence and extent of viable myocardium should be known in advance to select those patients who are likely to benefit most from revascularization procedures.
Positron emission tomography is often seen as the most accurate technique with which to assess myocardial viability pre-operatively and many studies have evaluated its accuracy for predicting recovery of cardiac function after revascularization [15] [16] [17] [18] [19] [20] [21] [22] . In most studies, however, recovery of cardiac function was assessed only in terms of improvement of regional wall motion abnormalities. Yet global left ventricular function is a more quantitative parameter, which correlates better with symptoms of heart failure, physical capacity and survival than regional wall motion. Hence, changes of global ejection fraction in individual patients are obviously a better end-point with which to assess the effect of revascularization of viable myocardium and to facilitate clinical decision making. However, because of the large study population needed to perform such analysis, limited data are available on the predictive accuracy of positron emission tomography for the recovery of global left ventricular function.
Initial studies using positron emission tomography for the assessment of myocardial viability relied on the analysis of the relative uptake of the perfusion tracer 13 N-labelled ammonia and FDG [15, 23] . Regions which showed a concordant reduction in both perfusion and FDG uptake ('flow-metabolism match') were shown to be infarcted and irreversibly injured, whereas regions in which FDG uptake was relatively preserved relative to perfusion ('flow-metabolism mismatch') were considered ischaemic and viable. Such studies were usually acquired during fasting conditions or after an oral glucose load and interpreted semi-qualitatively. However, many patients with coronary artery disease are insulin resistant [24, 25] , which results in poor FDG image quality after an oral glucose load. To circumvent this problem, use of the hyperinsulinaemic euglycaemic glucose clamp was advocated [26, 27] . Since quantitative analysis of FDG uptake might further enhance the detection of viable myocardium, the glucose clamp may allow such quantitative measurements to be performed under more rigorously standardized metabolic study conditions.
The aim of the Cardiology Branch of the Concerted Action of the European Community was to prospectively collect data from six European positron emission tomography centres to provide a sufficiently large database to permit measurements of diagnostic accuracy of positron emission tomography on an individual patient base, using recovery of global cardiac function as the primary end-point. Positron emission tomography imaging was performed under standardized metabolic conditions during a hyperinsulinaemic euglycaemic glucose clamp. A quantitative parameter, absolute myocardial glucose uptake, was chosen for the assessment of myocardial viability. Subgroup analysis was performed according to pre-operative ejection fraction, to determine which patients might benefit most from pre-operative assessment of viability by positron emission tomography.
Methods

Study protocol
This project was a prospectively designed multicentre trial aimed to evaluate the accuracy of quantitative FDG positron emission tomography during a euglycaemic hyperinsulinaemic glucose clamp for the assessment of myocardial viability. Patients from six European centres underwent a common positron emission tomography protocol.
Study population
A total of 259 patients with coronary artery disease underwent the common protocol of positron emission tomography using FDG, and were pooled into a common database. This study reports only on those 178 patients who completed the functional follow-up after successful coronary revascularization (Fig. 1) . The number of patients enrolled at each site was: Hammersmith Hospital, London 58 patients (33%), University of Louvain, Belgium 53 patients (30%), University of Turku, Finland 31 patients (17%), University of Lyon, France 21 patients (12%), University of Liege, Belgium 8 patients (4%) and University of Groningen, the Netherlands 7 patients (4%). The mean age of the patient population was 58 10 years (range from 34 to 77 years). Fourteen patients (8%) were of female gender and 19 (11%) were diabetic. Eighty-one percent of all patients had clinical evidence of previous myocardial infarction, the most recent occurring 13 days before the study. The decision to revascularize was based on clinical considerations. The study protocol was approved by the Ethical Committee of the participating centres, and all patients gave informed consent to the investigative nature of this study.
Coronary angiography
Significant coronary artery stenosis was defined as >75% lumen diameter stenosis in any major coronary branch. Complete occlusion of at least one major vessel was seen in 92 patients (the left anterior descending coronary artery in 50, the proximal circumflex in 23, and the right coronary artery in 61 patients). The remaining 89 patients had severe proximal stenosis of at least one major epicardial segment. Overall, 50 patients had single-vessel disease, 66 two vessel disease and 62 had three-vessel disease. Left main stenosis was present in 12 patients.
Assessment of cardiac function before and after revascularization
All patients underwent assessment of global and regional left ventricular function before and after coronary revascularization. The choice of the technique was left open to the investigator in each participating centre. However, the same technique had to be used in each patient before and after revascularization. Left ventricular ejection fraction was sequentially assessed by multiple gated angiography in 73 patients, by contrast angiography in 23 patients and by two-dimensional echocardiography in the remaining 75 patients. To assess regional wall motion, digitized 2D echocardiography was used in 108 patients, multiple gated angiography in 40 patients and contrast angiography in 23 patients. Regional wall motion before revascularization was interpreted in eight left ventricular segments (antero-basal, antero-septal, anterior, lateral, inferoseptal, apical, postero-basal and inferior) using a common scheme as proposed by Knuuti et al. [28] Wall motion in each segment was graded semi-quantitatively as normal (1), hypokinetic (2) or akinetic (3). The antero-basal, antero-septal, anterior and apical segments were ascribed to the territory of the left anterior descending coronary artery. Postero-basal and lateral segments were connected to the territory of the left circumflex artery and inferior and infero-septal segments were related to right coronary artery territory.
Euglycaemic hyperinsulinaemic glucose clamp
A euglycaemic hyperinsulinaemic glucose clamp was performed according to a standardized protocol, as described by De Fronzo [29] and Knuuti et al. [27] Briefly, insulin was infused intravenously, first at a rate of 0·16 U . min 1 . kg 1 for 4 min, then reduced to 0·08 U . min 1 . kg 1 for 3 min and finally maintained at 0·04 U . min 1 . kg 1 during the entire duration of the positron emission tomography. Arterialized blood samples were drawn at regular intervals for the determination of glycaemia. Glucose was co-infused at rates adapted to stabilize glycaemia at baseline values (Fig. 2) .
Positron emission tomography
Positron emission tomography was performed using standard equipment in each participating centre. Glucose uptake was measured after intravenous infusion of 10-15 mCi of the glucose analogue FDG using a multiframe dynamic emission scan over a 40-65 min acquisition time. The analysis of data was performed locally by each co-investigator. Using a common scheme [28] to relate wall-motion to positron emission tomography images, eight large regions of interest were hand-drawn on transaxial or re-orientated short-axis images to determine tissue activity over time. Another region in the centre of the left-ventricle was used to generate the tracer input function. Absolute myocardial glucose uptake was computed from fitted tissue time-activity curves using the linearized approach according to Gambhir et al. [30] . For standardization purposes, all values of regional glucose uptake were computed using a lumped constant of 1 and without any correction for partial volume effects. Glucose uptake was expressed in each segment, both in absolute values as well as normalized to the maximum value of the remote normally contracting segment in each patient.
Statistical analysis
All data are presented as mean one standard deviation. One-way analysis of variance was used to assess differences in continuous variables at baseline between centres. The chi-square test was used to assess differences in categorical variables at baseline. This test was also used to compare diagnostic accuracy of positron 
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emission tomography in subgroups of patients with different pre-operative ejection fractions. Receiver operative characteristic curves were generated to determine optimal threshold values for the sensitivity, specificity and accuracy of FDG positron emission tomography in predicting improvement of cardiac function. Optimal threshold values for absolute and normalized glucose metabolic rates were calculated using an iterative procedure for the presence of 1, 2, 3, 4 or more dysfunctional but viable segments. All statistical tests were two tailed, and a value of P<0·05 was considered indicative of statistical significance. The apical, lateral, posterior and inferior segments were completely akinetic. Mean glucose uptake in these dysfunctional segments was 37 µmole . min 1 . 100 g 1 (82% of remote). Six months after coronary bypass surgery, ejection fraction improved to 42%.
Results
Study population
Before revascularization mean left ventricular ejection fraction was 38 14%. There was a significant difference in ejection fraction between patients from different recruiting centres. Patients from Turku, Groningen and Lyon had a significantly higher ejection fraction than those from Brussels, London and Liege (Table 1 ). The ejection fraction was equal or less than 35% in 48% of all patients. No significant difference in coronary artery disease severity existed between patients from the six centres. On average, the patients had 4·1 1·9 dysfunctional cardiac segments which represents 51% of the total left ventricular myocardium. The average wall motion score before revascularization was 1·8 4·5. Revascularization was performed using bypass surgery in 140 patients (78%) and angioplasty in 38 (22%). There was no significant difference in the revascularization approach used within the different centres. Revascularization was considered to be complete (all significantly stenosed vessels treated) in 158 patients (89%). Nineteen patients had incomplete revascularization procedures: eight patients had single-vessel angioplasty in the presence of multiple vessel disease; another 11 patients had incomplete surgical revascularization (failure to graft the right coronary artery in eight patients and the circumflex artery in three patients). In 12 of these patients the non-revascularized area was normally contracting. Incomplete revascularization of a dysfunctional region was present in seven patients. Because incomplete revascularization might interfere with the postoperative improvement of myocardial function, these seven patients were not included in further analysis.
Euglycaemic glucose clamp
A euglycaemic glucose clamp was successfully performed using the standardized protocol in all patients (Fig. 2) . Baseline insulinaemia (before the clamp) was 18 12 (Fig. 3) . These findings were not accounted for by differences in metabolic conditions or in the analysis techniques. Indeed, similar inter-patient differences of the glucose uptake during the glucose clamp were also observed when analysis of pooled data was repeated by the same observer (A.B.). Because of these large variations in regional glucose uptake in normally contracting myocardium, values of glucose uptake in dysfunctional myocardium were normalized to those measured in the normally contracting remote myocardium of the same patient.
Prediction of improvement of global contractile function by positron emission tomography
The diagnostic performance of positron emission tomography was investigated on an individual patient basis. 
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Based on postoperative ejection fraction, patients were classified into two groups: group 1 (n=82) patients with a >5% increase in ejection fraction and group 2 (n=89) patients without postoperative improvement of ejection fraction (15 with no change, 32 with improvement <5% and 42 with deterioration) ( Table 2 ). Before revascularization, the clinical and angiographic data were similar in both groups of patients, with the exception of ejection fraction, which was significantly lower (P<0·005) in patients of group 1. Accordingly, the wall motion score of group 1 patients was also higher than in group 2 ( Table 2) . A significant correlation could be demonstrated between the changes in global ejection fraction and global wall motion score (r= 0·60, P<0·001). We then used iterative receiver operating curve analysis to determine the optimal cut-off points for the pre-operative prediction of recovery of global ejection fraction by more than 5% (Fig. 4) . As shown in Fig. 5 , three optimal cut-off points were identified by such analysis. The presence of more than three dysfunctional segments with a more than 45% normalized glucose uptake had the best sensitivity (79%) and specificity (55%) for predicting recovery of contractile function after revascularization (67% accuracy). The presence of only two viable segments with a higher cut-off value (60% normalized glucose uptake) had a higher sensitivity (87%) but a lower specificity (45%).
Subgroup analysis according to pre-operative ejection fraction
Because pre-operative assessment of viability is most important in patients with the most severely compromised ejection fraction, we also evaluated predictive accuracy separately in patients with a reduced and preserved pre-operative ejection fraction. Patients were separated into four subgroups, according to their preoperative ejection fraction. Results are shown in Fig. 6 . The diagnostic accuracy of positron emission tomography imaging was found to be similar in all patients, between 61% and 71%, irrespective of pre-operative ejection fraction, thus illustrating the usefulness of positron emission tomography for in all patient subgroups.
Discussion
The assessment of myocardial viability is a clinically important issue for the management of patients with post-ischaemic left ventricular dysfunction and particularly for those with the most severe impairment of left ventricular ejection fraction. Several studies [15] [16] [17] [18] [19] [20] [21] have assessed the predictive accuracy of positron emission tomography in detecting myocardial viability before coronary revascularization. Because of the size of the study populations, segmental rather than global left ventricular function has been assessed in most of these studies. Due to the limited spatial resolution of most imaging techniques, such evaluations of regional function have to be made semi-quantitatively, an approach that limits the precision of the assessment and is heavily dependent on the operator's subjective interpretation. For instance, the recovery of contractile function in a given segment may be incomplete because of the admixture of scarred with viable tissue. The presence of tethering from neighbouring infarcted segments as well as paradoxical movements of the heart after surgery may further distress the interpretation of regional cardiac function. Global ejection fraction, on the other hand, is a quantitative parameter, whose assessment is highly reproducible [31] . Because indices of global ventricular function reflect the functional outcome of the individual patient after revascularization, this end-point is to be preferred over the evaluation of regional cardiac function for the assessment of myocardial viability and clinical decision making.
In this study, we combined data from six positron emission tomography centres, to address the predictive accuracy of FDG positron emission tomography for the recovery of left ventricular ejection fraction after revascularization. In contrast to earlier semi-quantitative positron emission tomography studies based on the combined use of 13 N-ammonia and FDG, we have quantified myocardial FDG utilization during standardized and steady metabolic conditions, achieved by means of the euglycaemic hyperinsulinaemic glucose clamp technique. As previously shown by Ferrannini et al. [32] , Knuuti et al. [27] and Mäki et al. [33] , under such conditions, the substrate use of both the dysfunctional and normal myocardium shifts from fatty acid to glucose. During such maximal insulin stimulation, the magnitude of glucose uptake per unit of tissue correlates well with the amount of viable myocytes per unit of tissue [34] . Using the euglycaemic hyperinsulinaemic glucose clamp technique we anticipated that it should be possible to compare the absolute values of regional myocardial glucose uptake among different subjects thus allowing an absolute threshold of metabolic activity to be determined below which myocardial viability and recovery of function would not be expected. This, however, was not the case, because regional glucose uptake on an absolute scale varied largely in both remote normally contracting and dysfunctional regions on an inter-individual basis.
While we did not exactly understand the reason for these inter-individual variations of glucose uptake, a potential explanation might be the presence of insulin resistance, a condition often observed in patients with coronary artery disease [24, 35] . The findings might theoretically also be explained by variations of the lumped constant, which is the parameter that relates glucose uptake to the uptake of its analogue FDG. In in vitro experiments, it has been demonstrated that lumped 
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constant can be altered by modifications of metabolic conditions [36] . Whether this can be the case in vivo under standardized metabolic conditions of the euglycaemic glucose clamp is doubtful. Lastly, the wide range of normal values for glucose uptake might truly reflect normal biological variability, similar to the wide range of normal values for baseline myocardial blood flow [24] . Because of these large inter-individual variations, regional myocardial glucose uptake failed to accurately predict myocardial viability, when quantified in absolute terms. When normalized to remote myocardium of the same patient, however, values of regional myocardial glucose uptake were found to accurately foresee postoperative improvement of global cardiac function. Yet, in our study, the predictive accuracy of positron emission tomography for the improvement of global cardiac function was found to be somewhat lower than previously reported for segmental cardiac function [37] .
Because of the objective quantitative parameters used both for diagnosis of viability and outcome after revascularization and the considerably larger study population in our study, the present results might reflect the performance of the technique in clinical practice better than earlier studies performed in selected populations [15] [16] [17] [18] [19] [20] [21] .
Other reasons might also account for this finding. In many of the studies evaluating the recovery of regional cardiac function, the apex was represented as a single segment, and was thus under-represented in the overall evaluation of recovery of cardiac function, in spite of the fact that it amounts to 20% of left ventricular muscle mass. However, because of partial volume effects, the diagnostic accuracy of positron emission tomography is known to be reduced in apical segments. It is also possible that due to the presence of myocardial remodelling, segmental viability may have less impact on the recovery of global than of regional cardiac function. As in other previous studies, positron emission tomography was found to have a good sensitivity but only a modest specificity for the recovery of cardiac function after coronary revascularization. Several reasons might account for this. Myocyte viability and functional recovery are not synonymous, the latter being only one aspect of the former [38] . Recovery of function after revascularization is dependent on the interaction between the transmural extent of necrotic and viable tissue. Failure to improve function after revascularization may occur when the endocardium is necrosed and the epicardial rim of viable myocardium is tethered by the subendocardial scar. In such conditions positron emission tomography might be able to detect islands of truly viable tissue, but yet be too small to contribute to the recovery of global cardiac function. As indicated by the poor survival of patients with viable myocardium under medical treatment [6] [7] [8] [9] [10] , failure to detect recovery of function may be less of a problem than under-estimation of myocardial viability. Indeed, revascularization in the presence of viable areas of myocardium too small to contribute to recovery of function, may still improve long-term prognosis by preventing left ventricular remodelling, and by decreasing ischaemic and arrhythmic events.
Finally, another important finding of our study was that the accuracy of positron emission tomography for predicting recovery of contractile function was equally high in all patients, irrespective of pre-operative ejection ≥45% glucose uptake in ≥3 dysfunct. segm. ≥50% glucose uptake in ≥3 dysfunct. segm. ≥60% glucose uptake in ≥2 dysfunct. segm. 
Limitations
This study was multicentre based. Because of different local availability, diverse equipment was used for positron emission tomography studies. Also, assessment of pre-and postoperative ejection fraction was performed using three different techniques in the individual centres. Ejection fraction measurements by the different techniques may not be interchangeable [39] . However, the same equipment was used in all patients pre-and post-revascularization, thereby limiting variability in the individual patient. Although the reproducibility of these measurements could not be assessed in all centres for all techniques, reproducibility of radionuclide angiography and cineventriculography had been previously found to be high [31] . For 2D echocardiography using biplane Simpsons method, inter-and intra-observer variability was assessed in a subset of 10 patients in two centres (Turku and Brussels) and was found to be 5 6 and 4 3%, respectively, therefore allowing discrimination of changes of >5% in individual patients between the baseline and follow-up study.
Another potential limitation of the present study is that angiographic verification of the completeness of revascularization procedures was not regularly performed. We therefore cannot dismiss the possibility that early graft closure or restenosis prevented the recovery of function in patients with otherwise viable myocardium, resulting in reduced specificity. However, in those patients who underwent angiographic follow-up, such events were found to be rare. The impact of inadequate revascularization on the global results can therefore be expected to be low.
Conclusions
This study reported on the accuracy of positron emission tomography using quantitative parameters of regional myocardial glucose uptake for the prediction of global cardiac function after revascularization. We demonstrated high overall accuracy for the prediction of recovery of cardiac function. This accuracy was not influenced by pre-operative ejection fraction and remained excellent in the subgroup of patients with the most compromised cardiac function. Our study therefore supports the clinical use of FDG positron emission tomography for preoperative screening of myocardial viability in such patients.
